Kinnate Biopharma Inc.

2.26 USD
-0.03 (-1.31%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kinnate Biopharma Inc. stock is up 83.74% since 30 days ago. The next earnings date is Mar 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
11 Dec 17:39 21 Jun, 2024 2.50 PUT 500 13457
11 Dec 20:31 21 Jun, 2024 2.50 PUT 500 13457

About Kinnate Biopharma Inc.

Kinnate Biopharma focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors.